MarketCap
Facebook
X
Telegram
Molecular Templates Income Statement 2023-2001 | MTEM
Brief overview of financial performance at Molecular Templates
The figures are compared over a five-year interval. Revenue at Molecular Templates moved from 76.9 million dollars in 2015 to 18.8 million dollars in 2020. The cumulative result was −75.5%, corresponding to roughly −24.5% per year. Revenue ended the period on a sustained downward trend.
The gross result shifted from 76.9 million dollars to 18.8 million dollars, or −75.5%. Gross margin moved from 100% to 100%. The gross margin stayed within a similar range.
EBITDA changed from $27.2 million to −$96.9 million (−456%). The operating result developed less favorably than sales. Comparing the endpoints gives EBITDA margins of 35.4% and −514.3%. The margin contraction indicates weaker operating efficiency.
Across the five years, the net result shifted from 69.7 million dollars to −105 million dollars. Profit turned into a loss, the most concerning signal in the results.
Market capitalization changed from $247 million to $545 million (+120.4%). Capitalization rose despite deteriorating fundamentals.
What the figures show
The results contain several connected negative signals. Key strengths include steady gross profitability. The main areas of concern are a softer top-line trend, a low EBITDA margin and weaker operating efficiency. The key question is whether sales can be converted into sustainable profit.
Annual Income Statement Molecular Templates
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
10.1 M | 1.28 M | 170 M | 545 M | 564 M | 140 M | 123 M | 409 M | 247 M | 2.47 B | 3.1 B | 2.76 B | 666 M | - | - | - | - | - | - | - | - | - | - |
Shares |
4.5 M | 3.76 M | 55.3 M | 47.6 M | 37.8 M | 29.6 M | 11.4 M | 71.5 M | 70.2 M | 60.3 M | 57.8 M | 54.2 M | 45.9 M | 33.7 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
2.24 | 0.34 | 3.08 | 11.4 | 14.9 | 4.74 | 10.8 | 5.72 | 3.52 | 40.9 | 53.7 | 50.8 | 14.5 | - | - | - | - | - | - | - | - | - | - |
Net Income |
-8.12 M | -92.7 M | -83 M | -105 M | -69.4 M | -30.3 M | -23.1 M | -11 M | 69.7 M | -21.6 M | -28.4 M | -71.1 M | -25.7 M | -18.7 M | -23.6 M | -18.3 M | -30.7 M | -55.7 M | -44.4 M | -23.6 M | -8.3 M | -2.46 M | -236 K |
Revenue |
- | - | - | 18.8 M | 22.3 M | 13.3 M | 3.4 M | 1.88 M | 76.9 M | 14.7 M | 12.5 M | 5.87 M | 62 K | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 18.8 M | - | - | - | - | 76.9 M | 14.7 M | 12.5 M | 5.87 M | 62 K | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-10.5 M | -88.9 M | -80.1 M | -101 M | -70.4 M | -31 M | -17.8 M | -10.6 M | 26.9 M | -31.3 M | -26 M | -20 M | -30 M | -23.9 M | -21.3 M | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | 853 K | 431 K | 16.8 M | 9.34 M | -2.32 M | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-3.82 M | -81.5 M | -73.4 M | -96.9 M | -69.3 M | -30 M | -17.7 M | -10.4 M | 27.2 M | -30.9 M | -25.7 M | -19.8 M | -29.8 M | -23.4 M | -20.7 M | - | - | - | - | - | - | - | - |
Operating Expenses |
67.8 M | 109 M | 119 M | 120 M | 92.7 M | 44.3 M | 21.2 M | 12.5 M | 50 M | 46 M | 38.5 M | 25.9 M | 30.1 M | 23.9 M | 21.3 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.9 M | 26.2 M | 34.1 M | 26.7 M | 20.1 M | 14.1 M | 11.8 M | 4.48 M | 9.72 M | 10.1 M | 9.18 M | 7.08 M | 5.71 M | 4.97 M | 5.48 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Molecular Templates
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
6.56 M | 5.37 M | 5.37 M | 5.09 M | 56.4 M | 56.4 M | 3.76 M | 56.4 M | 56.3 M | 56.3 M | 56.3 M | 56.2 M | 56.1 M | 52.6 M | 50 M | 49 M | 45.7 M | 45.6 M | 45.6 M | 36.9 M | 36.8 M | 36.7 M | 36.7 M | 27.7 M | 27.1 M | 27 M | 26.9 M | 17.9 M | 71.6 M | 71.6 M | 215 K | 71.5 M | 71.5 M | 71.5 M | 71.5 M | 71.4 M | 71.3 M | 66.7 M | 62.9 M | 59.8 M | 59.3 M | 59.3 M | 59.2 M | 58.5 M | 57 M | 56.5 M | 56.4 M | 55.7 M | 54.5 M | 54.1 M | 49.1 M | 49.1 M | 48.8 M | 49.1 M |
Net Income |
-8.1 M | 572 K | - | -4.15 M | -23 K | 10.8 M | - | -70.7 M | -24.4 M | -21.6 M | - | -30.4 M | -15.6 M | -26.8 M | - | -23.2 M | -31.2 M | -22 M | - | -53.5 M | -9.15 M | -6.17 M | - | -5.24 M | -9.7 M | -8.71 M | - | -11 M | 1.14 M | -5.07 M | -3.68 M | -5.7 M | -6.86 M | -7.85 M | 69.7 M | -6.43 M | -8.31 M | -11.2 M | -5.96 M | -7.74 M | -766 K | -7.11 M | -7.59 M | 1.18 M | -12.8 M | -9.21 M | 28.4 M | -991 K | 17 M | -116 M | -5.28 M | -4.12 M | -7.92 M | -8.33 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.62 M | 5.45 M | 7.01 M | - | 6.75 M | 1.37 M | 482 K | - | 648 K | 42 K | 1.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 252 K | - | 5.03 M | 5.03 M | - |
Operating Income |
-8.3 M | -50 K | - | -5.14 M | -11.7 M | 11.8 M | - | -23.7 M | -23.5 M | -20.6 M | - | -29.5 M | -14.9 M | -26.3 M | - | -22.9 M | -29.9 M | -22.1 M | - | -38.3 M | -9.4 M | -6.38 M | - | -5.08 M | -10 M | -9.12 M | - | -5.87 M | 198 K | -4.44 M | - | -5.24 M | -5.91 M | -8.25 M | - | -6.77 M | -8.94 M | -9.62 M | - | -7.63 M | -7.46 M | -8.61 M | - | -5.22 M | -6.97 M | -6.06 M | - | -3.98 M | -2.88 M | -7.14 M | - | -7.79 M | -6.75 M | -7.39 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 279 K | 98 K | 295 K | - | -107 K | 913 K | -664 K | - | -498 K | -996 K | 370 K | - | 315 K | 596 K | -1.57 M | - | -341 K | 6.66 M | 1.46 M | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.13 M | 1.07 M | - | 310 K | -7.8 M | 13.7 M | - | -18.1 M | -19.8 M | -18.8 M | - | -24.7 M | -11.8 M | -24.8 M | - | -20.3 M | -28.6 M | -21.5 M | - | -37.6 M | -9.1 M | -6.2 M | - | -4.51 M | -9.83 M | -9.04 M | - | -5.8 M | 223 K | -4.42 M | - | -4.86 M | -5.6 M | -8.07 M | - | -6.02 M | -8.44 M | -9.38 M | - | -6.6 M | -6.74 M | -8.22 M | - | -4.13 M | -6.3 M | -5.74 M | - | -3.32 M | -2.55 M | -7.12 M | - | -7.39 M | -6.51 M | -7.31 M |
Operating Expenses |
8.87 M | 11.1 M | - | 11.9 M | 18.6 M | 24.8 M | - | 27.9 M | 27.9 M | 29.1 M | - | 31.9 M | 30 M | 29.5 M | - | 27.2 M | 36.8 M | 26.3 M | - | 41.9 M | 14.8 M | 13.4 M | - | 11.8 M | 11.4 M | 9.6 M | - | 6.52 M | 2.8 M | 4.44 M | - | 5.24 M | 5.91 M | 8.25 M | - | 10.5 M | 12.6 M | 13.3 M | - | 11.3 M | 11.1 M | 12.3 M | - | 8.4 M | 10.1 M | 8.98 M | - | 5.78 M | 4.68 M | 7.4 M | - | 7.79 M | 6.75 M | 7.39 M |
General and Administrative Expenses |
3.47 M | 3.73 M | - | 4.31 M | 5.2 M | 5.8 M | - | 5.93 M | 6.57 M | 7.62 M | - | 9.03 M | 8.92 M | 8.18 M | - | 7.55 M | 6.41 M | 5.65 M | - | 4.51 M | 4.6 M | 4.94 M | - | 3.54 M | 3.72 M | 2.91 M | - | 4 M | 1.69 M | 2.85 M | - | 1.72 M | 1.89 M | 2.25 M | - | 2.37 M | 2.48 M | 2.62 M | - | 2.41 M | 2.48 M | 2.63 M | - | 2.05 M | 2.17 M | 2.52 M | - | 1.74 M | 1.78 M | 1.71 M | - | 1.31 M | 1.68 M | 1.3 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Molecular Templates (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
USA
Canada
China
Israel
France
Germany
Britain
Russia
Belgium
Cayman-islands
